01-01-2011 | Original Article
Resistance to the proapoptotic effects of interferon-gamma on melanoma cells used in patient-specific dendritic cell immunotherapy is associated with improved overall survival
Published in: Cancer Immunology, Immunotherapy | Issue 1/2011
Login to get access